Effects of Mammography Screening Under Different Screening Schedules: Model Estimates of Potential Benefits and Harms

被引:477
|
作者
Mandelblatt, Jeanne S. [1 ]
Cronin, Kathleen A.
Bailey, Stephanie
Berry, Donald A.
de Koning, Harry J.
Draisma, Gerrit
Huang, Hui
Lee, Sandra J.
Munsell, Mark
Plevritis, Sylvia K.
Ravdin, Peter
Schechter, Clyde B.
Sigal, Bronislava
Stoto, Michael A.
Stout, Natasha K.
van Ravesteyn, Nicolien T.
Venier, John
Zelen, Marvin
Feuer, Eric J.
机构
[1] Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
关键词
CARCINOMA IN-SITU; BREAST-CANCER MORTALITY; UPPER AGE LIMIT; COST-EFFECTIVENESS; FOLLOW-UP; WOMEN; OLDER; OVERDIAGNOSIS; OVERTREATMENT; PERFORMANCE;
D O I
10.7326/0003-4819-151-10-200911170-00010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Despite trials of mammography and widespread use, optimal screening policy is controversial. Objective: To evaluate U. S. breast cancer screening strategies. Design: 6 models using common data elements. Data Sources: National data on age-specific incidence, competing mortality, mammography characteristics, and treatment effects. Target Population: A contemporary population cohort. Time Horizon: Lifetime. Perspective: Societal. Interventions: 20 screening strategies with varying initiation and cessation ages applied annually or biennially. Outcome Measures: Number of mammograms, reduction in deaths from breast cancer or life-years gained (vs. no screening), false-positive results, unnecessary biopsies, and overdiagnosis. Results of Base-Case Analysis: The 6 models produced consistent rankings of screening strategies. Screening biennially maintained an average of 81% (range across strategies and models, 67% to 99%) of the benefit of annual screening with almost half the number of false-positive results. Screening biennially from ages 50 to 69 years achieved a median 16.5% (range, 15% to 23%) reduction in breast cancer deaths versus no screening. Initiating biennial screening at age 40 years (vs. 50 years) reduced mortality by an additional 3% (range, 1% to 6%), consumed more resources, and yielded more false-positive results. Biennial screening after age 69 years yielded some additional mortality reduction in all models, but overdiagnosis increased most substantially at older ages. Results of Sensitivity Analysis: Varying test sensitivity or treatment patterns did not change conclusions. Limitation: Results do not include morbidity from false-positive results, patient knowledge of earlier diagnosis, or unnecessary treatment. Conclusion: Biennial screening achieves most of the benefit of annual screening with less harm. Decisions about the best strategy depend on program and individual objectives and the weight placed on benefits, harms, and resource considerations.
引用
收藏
页码:738 / W247
页数:15
相关论文
共 50 条
  • [21] THE POTENTIAL BENEFITS AND HARMS OF SCREENING FOR COLORECTAL-CANCER
    TOWLER, B
    IRWIG, L
    GLASZIOU, P
    HAAS, M
    PLUNKETT, A
    SALKELD, G
    AUSTRALIAN JOURNAL OF PUBLIC HEALTH, 1995, 19 (01): : 24 - 28
  • [22] The Benefits of Screening Mammography
    Charles De Jesus
    Tanya W. Moseley
    Valentina Diaz
    Varnita Vishwanath
    Shanen Jean
    Ahmed Elhatw
    Hanna R. Ferreira Dalla Pria
    Hannah L. Chung
    Mary S. Guirguis
    Miral M. Patel
    Current Breast Cancer Reports, 2023, 15 : 103 - 107
  • [23] The Benefits of Screening Mammography
    De Jesus, Charles
    Moseley, Tanya W.
    Diaz, Valentina
    Vishwanath, Varnita
    Jean, Shanen
    Elhatw, Ahmed
    Dalla Pria, Hanna R. Ferreira
    Chung, Hannah L. L.
    Guirguis, Mary S.
    Patel, Miral M.
    CURRENT BREAST CANCER REPORTS, 2023, 15 (02) : 103 - 107
  • [24] Benefits of Screening Mammography
    Berg, Wendie A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (02): : 168 - 169
  • [25] Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study
    Cao, Pianpian
    Jeon, Jihyoun
    Meza, Rafael
    JOURNAL OF MEDICAL SCREENING, 2022, 29 (04) : 260 - 267
  • [26] Risk-Based Mammography Screening: An Effort to Maximize the Benefits and Minimize the Harms
    Brawley, Otis W.
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (09) : 662 - 663
  • [27] Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study
    Oguzhan Alagoz
    Ali Hajjar
    Sarocha Chootipongchaivat
    Nicolien T. van Ravesteyn
    Jennifer M. Yeh
    Mehmet Ali Ergun
    Harry J. de Koning
    Brian Chicoine
    Barry Martin
    Journal of General Internal Medicine, 2019, 34 : 2374 - 2381
  • [28] The harms and benefits of modern screening mammography Women need more balanced information
    Elmore, Joann G.
    Harris, Russell P.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [29] Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study
    Alagoz, Oguzhan
    Hajjar, Ali
    Chootipongchaivat, Sarocha
    van Ravesteyn, Nicolien T.
    Yeh, Jennifer M.
    Ergun, Mehmet Ali
    de Koning, Harry J.
    Chicoine, Brian
    Martin, Barry
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2019, 34 (11) : 2374 - 2381
  • [30] Personalizing Age of Cancer Screening Cessation Based on Comorbid Conditions: Model Estimates of Harms and Benefits
    Lansdorp-Vogelaar, Iris
    Gulati, Roman
    Mariotto, Angela B.
    Schechter, Clyde B.
    de Carvalho, Tiago M.
    Knudsen, Amy B.
    van Ravesteyn, Nicolien T.
    Heijnsdijk, Eveline A. M.
    Pabiniak, Chester
    van Ballegooijen, Marjolein
    Rutter, Carolyn M.
    Kuntz, Karen M.
    Feuer, Eric J.
    Etzioni, Ruth
    de Koning, Harry J.
    Zauber, Ann G.
    Mandelblatt, Jeanne S.
    ANNALS OF INTERNAL MEDICINE, 2014, 161 (02) : 104 - +